• Oriva Therapeutics is launched with the support of Asabys, focused on developing innovative therapies in women’s health• The company incorporates two advanced assets from Oncostellae and Medibiofarma, addressing two high-unmet-need chronic conditions in women: endometriosis and uterine fibroids•Sabadell Asabys II has seeded the company, and the funds will be used to advance the clinical … Continue reading Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health